US Patent Issued to EUROPEAN MOLECULAR BIOLOGY LABORATORY, BOREA THERAPEUTICS on Feb. 17 for "Modified viral particles for gene therapy" (German Inventor)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,572, issued on Feb. 17, was assigned to EUROPEAN MOLECULAR BIOLOGY LABORATORY (Heidelberg, Germany) and BOREA THERAPEUTICS S.R.L. (Milan).

"Modified viral particles for gene therapy" was invented by Paul Alexander Heppenstall (Heidelberg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to novel surface modified viral capsids and recombinant virions comprising the same. Furthermore, this invention concerns intermediates for the preparation of surface modified viral capsids. The surface modified viral capsids are designed to selectively and/or more efficiently deliver gene therapy. The surface modified viral capsids, when...